Shareholders of Gene Logic have approved the sale of the company’s genomics assets to Ocimum Biosolutions and the subsequent renaming of the company as Ore Pharmaceuticals. The genomics sale is expected to close later this week and will effectively launch Ore Pharmaceuticals as a new company focused on drug repositioning and development. After the filing of necessary legal documents later this week, the company will be renamed officially. “Effective with the closing of the Ocimum ...